Sign up
Quantellect · Congress · Trade Detail
NASDAQ: EDITEditas Medicine Inc
DemocratHouse

Donald S. Beyer, Jr. bought Editas Medicine Inc (NASDAQ: EDIT)

Donald S. Beyer, Jr. (D-VA), a U.S. Representative, has disclosed 11 trades in Editas Medicine Inc (EDIT) since 2019, 7 purchases and 4 sales, worth an estimated $88K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Donald S. Beyer, Jr. bought $1,001 - $15,000 of Editas Medicine Inc (NASDAQ: EDIT) on January 9, 2020. Since that trade, EDIT is down -91.52% against the S&P 500 up +144.37%, an outperformance of -235.89%.

Across these filings, Donald S. Beyer, Jr. has been a net buyer of EDIT (a buy-to-sell ratio of 1.75). The most recent disclosed EDIT transaction shown was dated April 14, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

EDIT trades
11
Disclosed Vol
$88K
Buys
7
64%
Sells
4
36%
Buy / Sell
1.75
ratio
First → Last
2019–2021

Donald S. Beyer, Jr.'s EDIT trades vs the price

EDIT is down -91.52% since Donald S. Beyer, Jr. bought on January 9, 2020, versus +144.37% for the S&P 500.

Performance since this trade

Price change since trade
-91.52%
S&P 500 change since trade
+144.37%
Outperformance vs S&P 500
-235.89%

All Donald S. Beyer, Jr. EDIT trades

TradedTypeSizeReturnEst. profit
April 14, 2021SELL$41.53-93.74%
March 2, 2021SELL$45.69-94.31%
November 17, 2020BUY$28.75-90.96%-$7K
May 1, 2020SELL$22.20-88.29%
April 27, 2020SELL$25.40-89.76%
January 27, 2020BUY$27.97-90.70%-$7K
January 9, 2020BUY$30.65-91.52%-$7K
December 23, 2019BUY$32.24-91.94%-$7K
December 9, 2019BUY$30.32-91.42%-$7K
November 22, 2019BUY$24.36-89.33%-$7K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Donald S. Beyer, Jr. & EDIT trading FAQ

Is it legal for Donald S. Beyer, Jr. to trade Editas Medicine Inc (EDIT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Editas Medicine Inc (EDIT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Donald S. Beyer, Jr. buy EDIT?

Donald S. Beyer, Jr. disclosed a purchase of $1,001 - $15,000 of Editas Medicine Inc (EDIT) on January 9, 2020, according to public STOCK Act filings.

How has EDIT performed since Donald S. Beyer, Jr.'s trade?

Since Donald S. Beyer, Jr. bought EDIT on January 9, 2020, the stock is down -91.52%, versus +144.37% for the S&P 500 over the same period, an outperformance of -235.89%.

How many times has Donald S. Beyer, Jr. traded EDIT?

Donald S. Beyer, Jr. has disclosed 11 EDIT trades since 2019 (7 purchases and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional EDIT trades?

Quantellect tracks every disclosed congressional trade in Editas Medicine Inc (EDIT) on the Editas Medicine Inc congressional trading page, which aggregates filings across all members of Congress.

Donald S. Beyer, Jr.'s EDIT tradesAll congressional filings for Editas Medicine IncDonald S. Beyer, Jr.'s full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.